期刊文献+

促性腺激素释放激素激动剂对大鼠睾丸间质细胞annexin 5和3β-HSD的表达影响 被引量:9

Effects of GnRHa on annexin 5 and 3β-HSD expression in rat Leydig cells
下载PDF
导出
摘要 目的:探讨阿拉瑞林(GnRHa)对大鼠睾丸间质细胞中膜联蛋白V(annexin5)和3β-羟类固醇脱氢酶(3β-HSD)的表达的影响.方法:建立体外分离、纯化和培养大鼠睾丸间质细胞原代培养技术,采用3β-HSD免疫细胞化学方法对间质细胞进行鉴定,同时用不同终浓度的GnRHa(分别为1×10-5,1×10-6,1×10-7mol/L)作用于间质细胞24h后,通过Western Blot检测间质细胞中annexin5和3β-HSD的表达变化情况.结果:间质细胞经GnRHa处理后,Western Blot结果显示,与对照组相比,当GnRHa终浓度为1×10-5mol/L时,anenxin5的表达量显著升高了69.2%(P<0.01),3β-HSD的表达量也升高了25.2%(P<0.05);当GnRHa的终浓度为1×10-6mol/L和1×10-7mol/L时,anenxin5的表达量分别升高了61.5%(P<0.05)和16.64%(P>0.05),3β-HSD的表达量则无显著性变化,分别升高了7.7%(P>0.05)和2.22%(P>0.05).结论:GnRHa在原代培养的睾丸间质细胞中,对annexin5,3β-HSD的表达具有调节作用. AIM: To investigate the effects of GnRHa on the expression of annexin5 and 3β-HSD in rat Leydig cells. METHODS: The primary Leydig cells were isolated, purified and cultured in vitro. The cells were identified by 3β--HSD immunocytoehemistry method. Different concentrations of GnRHa ( 1 ×10^-5, 1 ×10^-6, 1 × 10^-7mol/L) were administrated on the Leydig ceils for 24 hour. The changes of annexin5 and 3β-HSD expression were investigated by Western blot. RESULTS: GnRHa stimulated the annexin5 and 3β-HSD expression. Treatment with 10-5mol/L of GnRHa increased annexin5 expression by 69.2% (P 〈 0.01 ) and 3β-HSD expression by 25.2% ( P 〈 0.05 ). Treatment with 10-6mol/L and 10-7 mol/L of GnRHa increased annexin5 expression by 61.5% and 16.64% ( P 〉 0.05 ) , and exerted no significant effects on 3 β-HSD expression (increased by 7.7% and 2.22% respectively, P 〉 0.05). CONCLUSION: GnRHa can regulate the annexin5 and 3β-HSD expression in pri- mary cultured Leydig cells.
出处 《第四军医大学学报》 北大核心 2009年第2期107-110,共4页 Journal of the Fourth Military Medical University
基金 国家自然科学基金(30770801)
关键词 促性腺素释放激素 细胞 培养的 大鼠 莱迪希细胞 膜联蛋白A5 3Β-HSD gonadorelin cells, cultured rats leydig cells annexin A5 3β-HSD
  • 相关文献

参考文献13

  • 1张超,刘欣燕.GnRH-a的临床应用进展[J].中国妇产科临床杂志,2007,8(3):229-231. 被引量:12
  • 2Millar RP, Lu ZL, Pawson AJ, et al. Gonadotropin-releasing hormone receptors [ J ]. Endocr Rev, 2004,25 (2) :235 - 275.
  • 3Bahk JY, Hyum JS, Chung SH, et al. Stage specific identification of the expression of GnRH mRNA and localization of the GnRH receptor in mature rat and adult human testis [ J]. J Urol, 1995,154(5) :1958 - 1961.
  • 4Chemes H, Cigorraga S, Bergada C, et al. Isolation of human Leydig cell mesenchymal precursors from patients with the androgen insensitivity syndrome: Testosterone production and response to human chorionic gonadotropin stimulation in culture [ J ]. Biol Reprod, 1992,46(5) :793 -801.
  • 5侯惠莲,张学斌,张冠军,李旭,王鸿雁,王敏,邓元.免疫细胞化学和形态学定量分析鉴别胸腹水良恶细胞的意义[J].第四军医大学学报,2007,28(1):62-64. 被引量:7
  • 6Spreca A, Rambotti MG, Giambanco I, et al. Immunocytochemical localization of annexin Ⅴ ( CaBP33 ), Ca ( 2 + ) -dependent phospholipid-and membrane-binding protein, in the rat nervous system and skeletal muscles and in the porcine heart[ J]. J Cell Physiol, 1992, 152(3) :587 -598.
  • 7Giambanco I, Pula G, Ceccarelli P, et al. Immunohistochemical localization of annexin Ⅴ ( CaBP33 ) in rat organs [ J ]. J Histochem Cytochem,1991,39(9) :1189 - 1198.
  • 8Kawaminarni M, Kawamoto T, Tanabe T, et al. Immunocytochemical localization of annexin 5, a calcium-dependent phospholipidbinding protein, in rat endocrine organs [ J ]. Cell Tissue Res, 1998,292( 1 ) : 85 -89.
  • 9Weiss JM, Krautmacher B, Polack S, et al. Actions of GnRH antagonists on IGF-Ⅱ, IGF-binding protein-2 and pregnancy-associated plasma protein-A in human granulosa-lutein cells [ J ]. Eur J Endocrinol, 2003,149(1) :31 -37.
  • 10Kawaminami M, Tsuchiyama Y, Saito S. Gonadotropin-releasing hormone stimulates annexin 5 messenger ribonucleic acd expression in the anterior pituitary cells [ J ]. Biochem Biophys Res Commun, 2002,291 (4) :915 -920.

二级参考文献43

  • 1龚玲,汪芳裕,张新华.γ-氨基丁酸及其受体在大鼠颌下腺表达和分布特征[J].医学研究生学报,2006,19(6):521-523. 被引量:5
  • 2[1]Lahlou N.Pharmacokinetics and pharmacodynamics of triptorelin.Ann Urol(Paris),2005,39:S78-S84.
  • 3[2]Carel JC.Treatment of precocious puberty by GnRH agonists.Ann Urol(Paris),2005,39:S85-S88.
  • 4[3]Hirsch HJ,Gillis D,Strich D,et al.The histrelin implant:a novel treatment for central precocious puberty.Pediatrics,2005,116:e798-e802.
  • 5[4]Sarah K,Zvi N,Rony S,et al.Gonadotropin-releasing hormone in apoptosis of prostate cancer cells.Cancer Letters,2006,234:109-123.
  • 6[5]Ratcliffe KE,Fraser HM,Sellar R,et al.Bifunctional Gonadotropin-Releasing Hormone Antagonist-Progesterone Analogs with Increased Efficacy and Duration of Action.Endocrinology,2006,147:571-579.
  • 7[6]Smith MR,Lee WC,Brandaman J,et al.Gonadotropin-releasing hormone agonists and fracture risk:a claims-based cohort study of men with nonmetastatic prostate cancer.J Clin Oncol,2005,23:7897-7903.
  • 8[7]Andrea DL,Marianna DF,Fabrizio P,et al.Clinical Response,Vascular Change,and Angiogenesis in Gonadotropin-Releasing Hormone Analogue-Treated Women With Uterine Myomas.J Soc Gynecol Investig,2005,12:123-128.
  • 9[8]Sallam HN,Garcia-Velasco JA,Dias S,et al.Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis.Cochrane Database Syst Rev,2006,1:4635-4636.
  • 10[9]Olive DL.Empirical therapy with leuprorelin acetate for endometriosis in the United States.Drugs Today(Barc),2005,41 Suppl A:5-10.

共引文献23

同被引文献124

引证文献9

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部